Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

Healthcare
IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in... see more

Recent & Breaking News (CSE:IMCC)

IMC to transfer its Oranim Pharmacy shares back to the seller

PR Newswire 9 days ago

Avant and IMC Execute BLK MKT(TM) Trademark Licensing Agreement for the German Medical Cannabis Market

PR Newswire April 4, 2024

Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC

Accesswire April 4, 2024

IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients

PR Newswire April 1, 2024

IM Cannabis Reports 2023 Financial Results

PR Newswire March 28, 2024

IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company

Canada NewsWire February 28, 2024

IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule

PR Newswire January 31, 2024

IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition

PR Newswire January 12, 2024

IMC Announces the Conclusion of the Planning and Construction Legal Proceedings

PR Newswire January 2, 2024

IM Cannabis Announces Receipt of Court Action

PR Newswire November 27, 2023

IM Cannabis Reports Third Quarter 2023 Financial Results

PR Newswire November 13, 2023

IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET

PR Newswire November 8, 2023

IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt

PR Newswire October 13, 2023

IM Cannabis Announces CFO Departure

PR Newswire September 19, 2023

IM Cannabis Reports Second Quarter 2023 Financial Results

Canada NewsWire August 14, 2023

IM Cannabis welcomes Israeli cannabis reforms

Jonathon Brown August 11, 2023

IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients

PR Newswire August 11, 2023

IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET

PR Newswire August 8, 2023

IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

PR Newswire August 4, 2023

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

PR Newswire June 13, 2023